{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:29:56Z","timestamp":1762900196879},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,9]]},"DOI":"10.7759\/cureus.18629","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T19:35:44Z","timestamp":1633894544000},"source":"Crossref","is-referenced-by-count":2,"title":["Late-Onset Euglycemic Diabetic Ketoacidosis in a Patient With Massive Stroke Requiring Decompressive Craniectomy: A Case Report"],"prefix":"10.7759","author":[{"given":"Syed Ahmed","family":"Hussaini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afia","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzamil","family":"Musa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Alamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Danjuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000187","article-title":"Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update","volume":"25","author":"Novikov A","year":"2016","unstructured":"Novikov A, Vallon V. Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update. Curr Opin Nephrol Hypertens. 2016, 25:50-8. 10.1097\/MNH.0000000000000187","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1747850","article-title":"Euglycemic diabetic ketoacidosis in the ICU: 3 case reports and review of literature","volume":"2018","author":"Lucero P","year":"2018","unstructured":"Lucero P, Chapela S. Euglycemic diabetic ketoacidosis in the ICU: 3 case reports and review of literature. Case Rep Crit Care. 2018, 2018:1747850. 10.1155\/2018\/1747850","journal-title":"Case Rep Crit Care"},{"key":"ref3","article-title":"Euglycemic Diabetic Ketoacidosis","author":"Plewa MC","year":"2020","unstructured":"Plewa MC, Bryant M, King-Thiele R. Euglycemic Diabetic Ketoacidosis. StatPearls Publishing, Treasure Island; 2020."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2019.03.014","article-title":"Euglycemic diabetic ketoacidosis","volume":"63","author":"Barski L","year":"2019","unstructured":"Barski L, Eshkoli T, Brandstaetter E, Jotkowitz A. Euglycemic diabetic ketoacidosis. Eur J Intern Med. 2019, 63:9-14. 10.1016\/j.ejim.2019.03.014","journal-title":"Eur J Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.6089","article-title":"Dapagliflozin-induced late-onset euglycemic diabetic ketoacidosis","volume":"11","author":"Iqbal I","year":"2019","unstructured":"Iqbal I, Hamid M, Khan MA, Kainat A, Tariq S. Dapagliflozin-induced late-onset euglycemic diabetic ketoacidosis. Cureus. 2019, 11:e6089. 10.7759\/cureus.6089","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/dbi18-0006","article-title":"Sodium-glucose cotransporter 2 inhibitors: a case study in translational research","volume":"68","author":"Beitelshees AL","year":"2019","unstructured":"Beitelshees AL, Leslie BR, Taylor SI. Sodium-glucose cotransporter 2 inhibitors: a case study in translational research. Diabetes. 2019, 68:1109-20. 10.2337\/dbi18-0006","journal-title":"Diabetes"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4365","article-title":"Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study","volume":"363","author":"Ueda P","year":"2018","unstructured":"Ueda P, Svanstr\u00f6m H, Melbye M, et al.. Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study. BMJ. 2018, 363:k4365. 10.1136\/bmj.k4365","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.11.002","article-title":"SGLT2 inhibitor-associated diabetic ketoacidosis: clinical review and recommendations for prevention and diagnosis","volume":"38","author":"Goldenberg RM","year":"2016","unstructured":"Goldenberg RM, Berard LD, Cheng AY, Gilbert JD, Verma S, Woo VC, Yale JF. SGLT2 inhibitor-associated diabetic ketoacidosis: clinical review and recommendations for prevention and diagnosis. Clin Ther. 2016, 38:2654-64. 10.1016\/j.clinthera.2016.11.002","journal-title":"Clin Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12401","article-title":"Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors","volume":"7","author":"Ogawa W","year":"2016","unstructured":"Ogawa W, Sakaguchi K. Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors. J Diabetes Investig. 2016, 7:135-8. 10.1111\/jdi.12401","journal-title":"J Diabetes Investig"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7074868","article-title":"Newer perspectives of mechanisms for euglycemic diabetic ketoacidosis","volume":"2018","author":"Yu X","year":"2018","unstructured":"Yu X, Zhang S, Zhang L. Newer perspectives of mechanisms for euglycemic diabetic ketoacidosis. Int J Endocrinol. 2018, 2018:7074868. 10.1155\/2018\/7074868","journal-title":"Int J Endocrinol"},{"key":"ref11","article-title":"Risks vs benefits for SGLT2 inhibitor medications","volume":"35","author":"Pittampalli S","year":"2018","unstructured":"Pittampalli S, Upadyayula S, Mekala HM, Lippmann S. Risks vs benefits for SGLT2 inhibitor medications. Fed Pract. 2018, 35:45-8.","journal-title":"Fed Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/pdi.2222","article-title":"SGLT inhibitors for people with type 1 diabetes","volume":"36","author":"Llano A","year":"2019","unstructured":"Llano A, McKay G, Fisher M. SGLT inhibitors for people with type 1 diabetes. Pract Diabetes. 2019, 36:91-6. 10.1002\/pdi.2222","journal-title":"Pract Diabetes"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0008","article-title":"SGLT inhibitors for type 1 diabetes: proceed with extreme caution","volume":"42","author":"Wolfsdorf JI","year":"2019","unstructured":"Wolfsdorf JI, Ratner RE. SGLT inhibitors for type 1 diabetes: proceed with extreme caution. Diabetes Care. 2019, 42:991-3. 10.2337\/dci19-0008","journal-title":"Diabetes Care"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1917241","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction. Reply","volume":"382","author":"McMurray JJ","year":"2020","unstructured":"McMurray JJ, Docherty KF, Jhund PS. Dapagliflozin in patients with heart failure and reduced ejection fraction. Reply. N Engl J Med. 2020, 382:973. 10.1056\/NEJMc1917241","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/73739-late-onset-euglycemic-diabetic-ketoacidosis-in-a-patient-with-massive-stroke-requiring-decompressive-craniectomy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:08Z","timestamp":1707507068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/73739-late-onset-euglycemic-diabetic-ketoacidosis-in-a-patient-with-massive-stroke-requiring-decompressive-craniectomy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.18629","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,9]]}}}